Z Geburtshilfe Neonatol 2021; 225(S 01): e50
DOI: 10.1055/s-0041-1739818
Abstracts | DGPM

Postnatal Outcome in Patients with Aortic Stenosis Undergoing Fetal Aortic Valvuloplasty: A Systematic Review and Meta-Analysis

R Axt-Fliedner
1   Justus-Liebig Universität Giessen, Abteilung fuer Pränatale Medizin&Fetale Therapie, Giessen, Deutschland
› Author Affiliations
 

Critical fetal aortic stenosis (AS) leads to stunted growth of the left ventricle (LV) and progresses to hypoplastic left heart syndrome (HLHS) if left untreated. To preserve the growth potential of the LV, fetal aortic valvuloplasty (FAV) became the treatment of choice at selected centers around the world. To this date, however, it is unclear in how many patients undergoing FAV worldwide, a biventricular circulation is ultimately achieved. The goal of this systematic review/meta-analysis is to determine whether there is sufficient clinical evidence to predict postnatal outcome in patients with AS following FAV to provide adequate prenatal counseling for this patient cohort.

Methods The methodology published by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement was applied. A systematic search on peri- and postnatal outcome in patients with AS following FAV was performed using MEDLINE, EMBASE, Web of Science and Cochrane Library.

Results An electronic search identified 579 studies, of which seven were considered eligible for analysis. A total of 266 fetuses underwent FAV with a follow-up ranging from 12 months to 13.2 years. There were no maternal deaths and only one FAV related maternal complication. Hydrops was present in 25 (9%) patients. Pooled prevalence of BV and UV among all live-born patients were 46%, 44%, respectively. Pooled prevalence of each secondary outcome was, technical successful procedures 82%; fetal deaths 16%, TOP 6%, live-births 79%, NND 9% comfort care 4%, late death 10%. Pooled prevalence for BV and UV among live-born patients that underwent technical successful procedures were 52% and 39.8%, respectively.

Conclusion Maternal FAV-related complications are rare and the majority of fetuses undergoing FAV are born alive. BVC following successful fetal intervention can be achieved in 52% of live-born patients compared to UVC. In summary, the current available published information can serve for prenatal parental counseling in this patient cohort. However, randomized clinical trials are necessary.



Publication History

Article published online:
26 November 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany